P. Terrier

614 total citations
22 papers, 309 citations indexed

About

P. Terrier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, P. Terrier has authored 22 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in P. Terrier's work include Sarcoma Diagnosis and Treatment (13 papers), Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). P. Terrier is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). P. Terrier collaborates with scholars based in France, Italy and United States. P. Terrier's co-authors include D. Vanel, M. Di Paola, L G Shapeero, T. de Baère, Eva Wardelmann, Cyril Fisher, Alexander J. Lazar, Judith V.M.G. Bovée, F. Collin and C. Lepéchoux and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Radiology.

In The Last Decade

P. Terrier

22 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Terrier France 9 206 126 118 60 51 22 309
Anja J. Rueten‐Budde Netherlands 10 293 1.4× 86 0.7× 199 1.7× 28 0.5× 55 1.1× 12 381
Stefano Lari Italy 6 271 1.3× 89 0.7× 167 1.4× 20 0.3× 106 2.1× 9 356
Karl-Peter Jungius Switzerland 8 70 0.3× 86 0.7× 30 0.3× 72 1.2× 98 1.9× 10 315
Yohei Asano Japan 10 143 0.7× 93 0.7× 75 0.6× 35 0.6× 65 1.3× 67 261
Christine Galant Belgium 8 122 0.6× 64 0.5× 70 0.6× 17 0.3× 59 1.2× 15 216
Susanne Scheipl Austria 8 119 0.6× 84 0.7× 38 0.3× 7 0.1× 45 0.9× 22 226
Hexiang Wang China 12 188 0.9× 61 0.5× 80 0.7× 211 3.5× 68 1.3× 21 345
Claudia Ortega Canada 12 162 0.8× 100 0.8× 26 0.2× 222 3.7× 64 1.3× 52 435
Harbir Sidhu United Kingdom 14 313 1.5× 43 0.3× 73 0.6× 338 5.6× 66 1.3× 27 538
Weidong Zhang China 14 136 0.7× 111 0.9× 54 0.5× 94 1.6× 84 1.6× 25 361

Countries citing papers authored by P. Terrier

Since Specialization
Citations

This map shows the geographic impact of P. Terrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Terrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Terrier more than expected).

Fields of papers citing papers by P. Terrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Terrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Terrier. The network helps show where P. Terrier may publish in the future.

Co-authorship network of co-authors of P. Terrier

This figure shows the co-authorship network connecting the top 25 collaborators of P. Terrier. A scholar is included among the top collaborators of P. Terrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Terrier. P. Terrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumont, Sarah, C. Le Péchoux, Charles Honoré, et al.. (2018). Pazopanib in advanced or metastatic synovial sarcoma: The Gustave Roussy experience. Annals of Oncology. 29. viii589–viii590. 2 indexed citations
2.
3.
Assi, Hazem, G. Missenard, P. Terrier, et al.. (2010). Intensive Induction Chemotherapy without Methotrexate in Adult Patients with Localized Osteosarcoma: Results of the Institut Gustave-Roussy Phase II Trial. Current Oncology. 17(6). 23–31. 28 indexed citations
4.
Bidault, François, D. Vanel, P. Terrier, et al.. (2009). Liposarcoma or lipoma: Does genetics change classic imaging criteria?. European Journal of Radiology. 72(1). 22–26. 9 indexed citations
5.
Cesne, Axel Le, P. Terrier, Sylvie Bonvalot, et al.. (2008). Clear cell sarcoma (CCS) or malignant melanoma of soft parts: A retrospective clinicopathologic study of 52 cases. Journal of Clinical Oncology. 26(15_suppl). 10576–10576. 1 indexed citations
6.
Vanel, D., A. Le Cesne, Sylvie Bonvalot, et al.. (2005). Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. Clinical Imaging. 29(6). 446–446. 4 indexed citations
7.
Robert, Caroline, et al.. (2005). BRAF and NRAS mutational status in clear cell sarcoma. Journal of Clinical Oncology. 23(16_suppl). 9000–9000. 1 indexed citations
8.
Bachmeyer, Claude, et al.. (2004). Tumeur fibreuse solitaire du cou. La Revue de Médecine Interne. 25(9). 683–684. 1 indexed citations
9.
Zelek, Laurent, Antonio Llombart‐Cussac, P. Terrier, & Janice N. Cormier. (2004). Prognostic factors in primary breast sarcomas: A series of patients with long-term follow-up. 15(1). 54–55. 6 indexed citations
10.
Abuin, Gonzalo Gómez, S. Bonvalot, P. Terrier, et al.. (2004). Intensive induction chemotherapy (API-AI regimen) followed by conservative surgery in adult patients with locally advanced soft tissue sarcoma (STS): Survival is predicted by the histological response. Journal of Clinical Oncology. 22(14_suppl). 9036–9036. 2 indexed citations
11.
Guetz, G. Des, Olivier Delattre, Dominique Ranchère‐Vince, et al.. (2004). Study of the prognostic value and chemosensitivity according to the type of translocation in synovial sarcoma. Journal of Clinical Oncology. 22(14_suppl). 9016–9016. 1 indexed citations
12.
Terrier, P., et al.. (2002). [Pulmonary carcinosarcoma with jejunal metastasis: complete response to chemotherapy].. PubMed. 58(4 Pt 1). 249–52. 2 indexed citations
13.
Ladetto, Q., et al.. (2000). Human Walking Analysis Assisted by DGPS. Infoscience (Ecole Polytechnique Fédérale de Lausanne). 22 indexed citations
14.
Koscielny, Serge, P. Terrier, M. Spielmann, & J Delarue. (1999). RESPONSE: Re: Prognostic Importance of Low c-erbB2 Expression in Breast Tumors. JNCI Journal of the National Cancer Institute. 91(18). 1585–1585. 1 indexed citations
15.
Koscielny, Serge, P. Terrier, A Daver, et al.. (1998). Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values. European Journal of Cancer. 34(4). 476–481. 22 indexed citations
16.
Fizazi, Karim, Jean Feuillard, Axel Le Cesne, et al.. (1996). Soft tissue sarcomas in HIV-infected adult patients. European Journal of Cancer. 32(10). 1812–1814. 10 indexed citations
17.
Oberlin, Odile, J. Lumbroso, P. Terrier, et al.. (1994). Negative 123‐meta‐lodobenzyl‐guanidine imaging in Ewing's sarcoma of bone. Medical and Pediatric Oncology. 23(2). 130–132. 2 indexed citations
18.
Delarue, J, et al.. (1994). Combined overexpression of c-erbB-2 protein and epidermal growth factor receptor (EGF-R) could be predictive of early and long-term outcome in human breast cancer: a pilot study.. PubMed. 81(12). 1067–77. 12 indexed citations
19.
Baère, T. de, et al.. (1992). Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.. Radiology. 185(2). 587–592. 76 indexed citations
20.
Martı́nez-Madrigal, Fernando, D. Vanel, B Luboïnski, & P. Terrier. (1991). Case report 670. Skeletal Radiology. 20(4). 299–301. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja J. Rueten‐Budde Breakdown of academic impact, for papers by Stefano Lari Breakdown of academic impact, for papers by Karl-Peter Jungius Breakdown of academic impact, for papers by Yohei Asano Breakdown of academic impact, for papers by Christine Galant Breakdown of academic impact, for papers by Susanne Scheipl Breakdown of academic impact, for papers by Hexiang Wang Breakdown of academic impact, for papers by Claudia Ortega Breakdown of academic impact, for papers by Harbir Sidhu Breakdown of academic impact, for papers by Weidong Zhang
Rankless by CCL
2026